[1]
Nasreen, F. et al. 2016. Outcome of Well-Differentiated Thyroid Carcinoma Patients Receiving a Cumulative Doses of ? 600 mCi (22GBq) of I-131. Bangladesh Journal of Nuclear Medicine. 17, 2 (Jun. 2016), 114–119. DOI:https://doi.org/10.3329/bjnm.v17i2.28195.